Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel:	Blood
Personen und Körperschaften:	Jain, Preetesh, Keating, Michael, Wierda, William, Estrov, Zeev, Ferrajoli, Alessandra, Jain, Nitin, George, Binsah, James, Danelle, Kantarjian, Hagop, Burger, Jan, O’Brien, Susan
In:	Blood, 125, 2015, 13, S. 2062-2067
Format:	E-Article
Sprache:	Englisch
veröffentlicht:	American Society of Hematology
Schlagwörter:	Cell Biology Hematology Immunology Biochemistry

Details
Zusammenfassung:	<jats:title>Key Points</jats:title> <jats:p>Clinical characteristics, causes of discontinuation, and outcome of patients who progress or fail ibrutinib are described. Patients with CLL who progress early on ibrutinib therapy have poor outcomes.</jats:p>
Umfang:	2062-2067
ISSN:	0006-4971 1528-0020
DOI:	10.1182/blood-2014-09-603670